UDOW vs. CURE
UDOW (ProShares UltraPro Dow30) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - UDOW tracks the Dow Jones Industrial Average (300%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, UDOW returned 23.30%/yr vs 11.65%/yr for CURE. A 0.71 correlation means they provide meaningful diversification when combined. UDOW charges 0.95%/yr vs 1.08%/yr for CURE.
Performance
UDOW vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UDOW achieves a 12.27% return, which is significantly higher than CURE's -18.38% return. Over the past 10 years, UDOW has outperformed CURE with an annualized return of 23.30%, while CURE has yielded a comparatively lower 11.65% annualized return.
UDOW
- 1D
- -3.38%
- 1M
- 10.84%
- YTD
- 12.27%
- 6M
- 12.78%
- 1Y
- 53.13%
- 3Y*
- 33.01%
- 5Y*
- 12.75%
- 10Y*
- 23.30%
CURE
- 1D
- 2.17%
- 1M
- 4.39%
- YTD
- -18.38%
- 6M
- -18.70%
- 1Y
- 21.60%
- 3Y*
- -0.15%
- 5Y*
- 0.21%
- 10Y*
- 11.65%
UDOW vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UDOW ProShares UltraPro Dow30 | 12.27% | 24.46% | 28.47% | 32.72% | -32.39% | 65.67% | -17.15% | 75.24% | -23.86% | 99.07% |
CURE Direxion Daily Healthcare Bull 3x Shares | -18.38% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between UDOW and CURE is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.63 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.68 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2011 | 0.71 |
The correlation between UDOW and CURE shifts across timeframes, from 0.51 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.
UDOW vs. CURE - Sectors Allocation Comparison
Sectors
UDOW
CURE
Financial Services
-
Industrials
-
Technology
-
Healthcare
Consumer Cyclical
-
Consumer Defensive
-
Basic Materials
-
Energy
-
Communication Services
-
Real Estate
-
-
Utilities
-
-
Financial Services
UDOW
CURE
-
Industrials
UDOW
CURE
-
Technology
UDOW
CURE
-
Healthcare
UDOW
CURE
Consumer Cyclical
UDOW
CURE
-
Consumer Defensive
UDOW
CURE
-
Basic Materials
UDOW
CURE
-
Energy
UDOW
CURE
-
Communication Services
UDOW
CURE
-
Real Estate
UDOW
-
CURE
-
Utilities
UDOW
-
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UDOW vs. CURE — Risk / Return Rank
UDOW
CURE
UDOW vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UDOW | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.98 | ||
| Sortino ratioReturn per unit of downside risk | +1.05 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.12 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.90 | 0.70 | +1.20 |
| Martin ratioReturn relative to average drawdown | 6.75 | 1.61 | +5.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UDOW | CURE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.48 | 0.50 | +0.98 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.00 | +0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.45 | 0.24 | +0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.53 | 0.46 | +0.07 |
Drawdowns
UDOW vs. CURE - Drawdown Comparison
The maximum UDOW drawdown since its inception was -80.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UDOW and CURE.
Loading charts...
Drawdown Indicators
| UDOW | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.29% | -69.19% | -11.10% |
Max Drawdown (1Y)Largest decline over 1 year | -28.07% | -31.10% | +3.03% |
Max Drawdown (3Y)Largest decline over 3 years | -44.83% | -51.93% | +7.10% |
Max Drawdown (5Y)Largest decline over 5 years | -55.79% | -52.23% | -3.56% |
Max Drawdown (10Y)Largest decline over 10 years | -80.29% | -69.19% | -11.10% |
Current DrawdownCurrent decline from peak | -3.38% | -35.21% | +31.83% |
Average DrawdownAverage peak-to-trough decline | -14.39% | -18.15% | +3.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.90% | 13.43% | -5.53% |
Volatility
UDOW vs. CURE - Volatility Comparison
The current volatility for ProShares UltraPro Dow30 (UDOW) is 8.80%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 11.99%. This indicates that UDOW experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UDOW | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.80% | 11.99% | -3.19% |
Volatility (6M)Calculated over the trailing 6-month period | 27.61% | 29.83% | -2.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.12% | 43.19% | -7.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.19% | 43.69% | +0.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.76% | 49.51% | +2.25% |
UDOW vs. CURE - Expense Ratio Comparison
UDOW has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
UDOW vs. CURE - Dividend Comparison
UDOW's dividend yield for the trailing twelve months is around 1.21%, less than CURE's 1.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.31% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
UDOW ProShares UltraPro Dow30 | 1.21% | 1.38% | 0.95% | 0.95% | 0.83% | 0.26% | 0.19% | 0.61% | 0.73% | 0.13% | 0.26% | 0.21% |
Frequently Asked Questions
UDOW and CURE have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (11.99%) compared to UDOW (8.80%). In terms of maximum drawdown, UDOW dropped -80.29% vs CURE's -69.19%.
On 10-year performance, UDOW leads with 23.30% vs 11.65% for CURE. On fees, UDOW is cheaper at 0.95% per year. On volatility, UDOW has been the lower-risk option at 8.80%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UDOW has performed better with a 23.30% return vs 11.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UDOW is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.31%, compared with 1.21% for UDOW.
UDOW tracks Dow Jones Industrial Average (300%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UDOW and 1.08% for CURE.
UDOW currently has the higher Sharpe Ratio (1.48 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UDOW and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer